CRISPR knockout or shRNA knockdown of CCR2 in DCIS.com cells inhibited CCL2-mediated growth, EMT and invasion, corresponding to decreased ALDHA1 expression and increased HTRA2 expression. The gene discussed is HTRA2; the disease is ductal breast carcinoma in situ.